PPT Slide
aPTT in Patients Receiving UFH
ESSENCEStudy Design
ESSENCEResults
CONCLUSIONS
TIMI 11BStudy Design
TIMI 11BResults: Early Treatment Phase
TIMI 11BResults: Primary Endpoint
TIMI 11B-ESSENCE Meta-Analysis
TIMI 11B-ESSENCE Meta-Analysis Results: Death/MI
TIMI 11B-ESSENCE Meta-Analysis One-Year Follow-up
TIMI 11B-ESSENCE Meta-Analyses Conclusions
Clinical Event Rates in UA/NSTEMI Trials
PURSUITResults
INTERACTResults
Pharmacokinetics of Enoxaparin
ACC/AHA 2002 GuidelinesManagement of UA/NSTEMI
What are the new labeling changes?
NEW WARNING:
NEW PRECAUTIONS:
Mechanical Valve Thrombosis with Enoxaparin
South African Study
ACCP Recommendations Pregnant Patients with Mechanical Valves
Peri-Procedure Bridgingwith Enoxaparin
“Bridge” Therapy: Cost Effectiveness
Summary: Enoxaparin Bridging
ACCP-Management of Oral Anticoagulation During Invasive Procedures
www.CareInternet.com
Email: slideshows@careinternet.net
Home Page: http://www.careinternet.com